BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $21.0B | +15.2% |
| Gross profit | $14.7B | +16.5% |
| Operating income | $4.2B | — |
| Net income | $3.7B | — |
| EPS | $2.47 | — |
| Free cash flow | $3.6B | +26.4% |